101 related articles for article (PubMed ID: 19201107)
21. Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis.
Huang WY; Olshan AF; Schwartz SM; Berndt SI; Chen C; Llaca V; Chanock SJ; Fraumeni JF; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1747-53. PubMed ID: 16030112
[TBL] [Abstract][Full Text] [Related]
22. [Genetic epidemiology and twin research].
Irgens LM
Tidsskr Nor Laegeforen; 1999 Sep; 119(22):3251. PubMed ID: 10533403
[No Abstract] [Full Text] [Related]
23. Upper gastrointestinal cancer predisposition syndromes.
Shah MA; Kurtz RC
Hematol Oncol Clin North Am; 2010 Oct; 24(5):815-35. PubMed ID: 20816576
[TBL] [Abstract][Full Text] [Related]
24. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
26. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study.
Chang KP; Hao SP; Liu CT; Cheng MH; Chang YL; Lee YS; Wang TH; Tsai CN
Oral Oncol; 2007 Apr; 43(4):345-51. PubMed ID: 16920385
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
[TBL] [Abstract][Full Text] [Related]
29. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
31. Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer.
Neuhaus T; Ko YD; Lorenzen K; Fronhoffs S; Harth V; Bröde P; Vetter H; Bolt HM; Pesch B; Brüning T
Toxicol Lett; 2004 Jun; 151(1):273-82. PubMed ID: 15177663
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
33. [Genetic diagnosis of cancers? Which cancers should be screened?].
Chompret A
Ann Med Interne (Paris); 2001 Jun; 152(4):249-61. PubMed ID: 11474373
[TBL] [Abstract][Full Text] [Related]
34. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
[TBL] [Abstract][Full Text] [Related]
35. Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk.
Reszka E; Wasowicz W
Int J Occup Med Environ Health; 2001; 14(2):99-113. PubMed ID: 11548073
[TBL] [Abstract][Full Text] [Related]
36. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
37. Hereditary cancer syndromes of the skin.
Somoano B; Niendorf KB; Tsao H
Clin Dermatol; 2005; 23(1):85-106. PubMed ID: 15708293
[TBL] [Abstract][Full Text] [Related]
38. A case-control study on the effect of apoliprotein E genotype on head and neck cancer risk.
De Feo E; Rowell J; Cadoni G; Nicolotti N; Arzani D; Giorgio A; Amore R; Paludetti G; Ricciardi G; Boccia S
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2839-46. PubMed ID: 20861397
[TBL] [Abstract][Full Text] [Related]
39. Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project.
Canova C; Hashibe M; Simonato L; Nelis M; Metspalu A; Lagiou P; Trichopoulos D; Ahrens W; Pigeot I; Merletti F; Richiardi L; Talamini R; Barzan L; Macfarlane GJ; Macfarlane TV; Holcátová I; Bencko V; Benhamou S; Bouchardy C; Kjaerheim K; Lowry R; Agudo A; Castellsagué X; Conway DI; McKinney PA; Znaor A; McCartan BE; Healy CM; Marron M; Brennan P
Cancer Res; 2009 Apr; 69(7):2956-65. PubMed ID: 19339270
[TBL] [Abstract][Full Text] [Related]
40. Cancer, genes, and the environment.
Begg CB
N Engl J Med; 2000 Nov; 343(20):1495; discussion 1495-6. PubMed ID: 11184466
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
